Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | (1->4)-beta-D-glucan | multiple interactions | ISO | Hacd2 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of HACD2 mRNA | CTD | PMID:36331819 | 17alpha-ethynylestradiol | affects expression | ISO | HACD2 (Homo sapiens) | 6480464 | Ethinyl Estradiol affects the expression of HACD2 mRNA | CTD | PMID:20170705 | 17alpha-ethynylestradiol | decreases expression | ISO | Hacd2 (Mus musculus) | 6480464 | Ethinyl Estradiol results in decreased expression of HACD2 mRNA | CTD | PMID:17942748 | 17beta-estradiol | increases expression | ISO | HACD2 (Homo sapiens) | 6480464 | Estradiol results in increased expression of HACD2 mRNA | CTD | PMID:31614463 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Hacd2 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of HACD2 mRNA | CTD | PMID:21570461 | 2,4-diaminotoluene | decreases expression | ISO | Hacd2 (Mus musculus) | 6480464 | 2 and 4-diaminotoluene results in decreased expression of HACD2 mRNA | CTD | PMID:20713471 | 2,4-dinitrotoluene | affects expression | EXP | | 6480464 | 2 and 4-dinitrotoluene affects the expression of HACD2 mRNA | CTD | PMID:21346803 | 2-methylcholine | affects expression | ISO | HACD2 (Homo sapiens) | 6480464 | beta-methylcholine affects the expression of HACD2 mRNA | CTD | PMID:21179406 | 4,4'-sulfonyldiphenol | increases expression | ISO | HACD2 (Homo sapiens) | 6480464 | bisphenol S results in increased expression of HACD2 mRNA | CTD | PMID:27685785 | 4-hydroxyphenyl retinamide | increases expression | ISO | Hacd2 (Mus musculus) | 6480464 | Fenretinide results in increased expression of HACD2 mRNA | CTD | PMID:28973697 | aflatoxin B1 | decreases methylation | ISO | HACD2 (Homo sapiens) | 6480464 | Aflatoxin B1 results in decreased methylation of HACD2 gene | CTD | PMID:27153756 | all-trans-retinoic acid | decreases expression | ISO | HACD2 (Homo sapiens) | 6480464 | Tretinoin results in decreased expression of HACD2 mRNA | CTD | PMID:33167477 | aristolochic acid A | decreases expression | ISO | HACD2 (Homo sapiens) | 6480464 | aristolochic acid I results in decreased expression of HACD2 mRNA | CTD | PMID:33212167 | arsane | affects methylation | ISO | HACD2 (Homo sapiens) | 6480464 | Arsenic affects the methylation of HACD2 gene | CTD | PMID:25304211 | arsenic atom | affects methylation | ISO | HACD2 (Homo sapiens) | 6480464 | Arsenic affects the methylation of HACD2 gene | CTD | PMID:25304211 | benzo[a]pyrene | decreases expression | ISO | Hacd2 (Mus musculus) | 6480464 | Benzo(a)pyrene results in decreased expression of HACD2 mRNA | CTD | PMID:20713471 | benzo[a]pyrene diol epoxide I | decreases expression | ISO | HACD2 (Homo sapiens) | 6480464 | 7 more ... | CTD | PMID:20018196 and PMID:26238291 | bis(2-ethylhexyl) phthalate | decreases expression | ISO | HACD2 (Homo sapiens) | 6480464 | Diethylhexyl Phthalate results in decreased expression of HACD2 protein | CTD | PMID:31163220 | bisphenol A | affects expression | ISO | HACD2 (Homo sapiens) | 6480464 | bisphenol A affects the expression of HACD2 mRNA | CTD | PMID:20170705 | bisphenol A | decreases methylation | ISO | HACD2 (Homo sapiens) | 6480464 | bisphenol A results in decreased methylation of HACD2 gene | CTD | PMID:31601247 | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of HACD2 mRNA | CTD | PMID:32145629 | bisphenol A | decreases expression | ISO | Hacd2 (Mus musculus) | 6480464 | bisphenol A results in decreased expression of HACD2 mRNA | CTD | PMID:26063408 and PMID:26512966 | buspirone | decreases expression | EXP | | 6480464 | Buspirone results in decreased expression of HACD2 mRNA | CTD | PMID:24136188 | butanal | decreases expression | ISO | HACD2 (Homo sapiens) | 6480464 | butyraldehyde results in decreased expression of HACD2 mRNA | CTD | PMID:26079696 | calcitriol | increases expression | ISO | HACD2 (Homo sapiens) | 6480464 | Calcitriol results in increased expression of HACD2 mRNA | CTD | PMID:26485663 | carbon nanotube | decreases expression | ISO | Hacd2 (Mus musculus) | 6480464 | Nanotubes more ... | CTD | PMID:25620056 | carbon nanotube | increases expression | ISO | Hacd2 (Mus musculus) | 6480464 | Nanotubes more ... | CTD | PMID:25554681 | choline | multiple interactions | ISO | Hacd2 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of HACD2 mRNA | CTD | PMID:20938992 | ciguatoxin CTX1B | affects expression | ISO | Hacd2 (Mus musculus) | 6480464 | Ciguatoxins affects the expression of HACD2 mRNA | CTD | PMID:18353800 | cisplatin | decreases expression | ISO | HACD2 (Homo sapiens) | 6480464 | Cisplatin results in decreased expression of HACD2 mRNA | CTD | PMID:27392435 | clothianidin | increases expression | ISO | HACD2 (Homo sapiens) | 6480464 | clothianidin results in increased expression of HACD2 mRNA | CTD | PMID:29044138 | cyclosporin A | decreases expression | ISO | HACD2 (Homo sapiens) | 6480464 | Cyclosporine results in decreased expression of HACD2 mRNA | CTD | PMID:20106945 | dexamethasone | increases expression | ISO | HACD2 (Homo sapiens) | 6480464 | Dexamethasone results in increased expression of HACD2 mRNA | CTD | PMID:25047013 | dibutyl phthalate | decreases expression | EXP | | 6480464 | Dibutyl Phthalate results in decreased expression of HACD2 mRNA | CTD | PMID:21266533 | doxorubicin | decreases expression | ISO | HACD2 (Homo sapiens) | 6480464 | Doxorubicin results in decreased expression of HACD2 mRNA | CTD | PMID:29803840 | ethanol | affects splicing | ISO | Hacd2 (Mus musculus) | 6480464 | Ethanol affects the splicing of HACD2 mRNA | CTD | PMID:30319688 | finasteride | increases expression | EXP | | 6480464 | Finasteride results in increased expression of HACD2 mRNA | CTD | PMID:24136188 | folic acid | multiple interactions | ISO | Hacd2 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of HACD2 mRNA | CTD | PMID:20938992 | formaldehyde | decreases expression | ISO | HACD2 (Homo sapiens) | 6480464 | Formaldehyde results in decreased expression of HACD2 mRNA | CTD | PMID:23649840 | geldanamycin | increases expression | ISO | HACD2 (Homo sapiens) | 6480464 | geldanamycin results in increased expression of HACD2 mRNA | CTD | PMID:26705709 | gentamycin | decreases expression | EXP | | 6480464 | Gentamicins results in decreased expression of HACD2 mRNA | CTD | PMID:33387578 | L-methionine | multiple interactions | ISO | Hacd2 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of HACD2 mRNA | CTD | PMID:20938992 | mercury dichloride | decreases expression | ISO | HACD2 (Homo sapiens) | 6480464 | Mercuric Chloride results in decreased expression of HACD2 mRNA | CTD | PMID:27188386 | methylseleninic acid | decreases expression | ISO | HACD2 (Homo sapiens) | 6480464 | methylselenic acid results in decreased expression of HACD2 mRNA | CTD | PMID:18548127 | monosodium L-glutamate | decreases expression | ISO | Hacd2 (Mus musculus) | 6480464 | Sodium Glutamate results in decreased expression of HACD2 mRNA | CTD | PMID:22078008 | nickel atom | decreases expression | ISO | HACD2 (Homo sapiens) | 6480464 | Nickel results in decreased expression of HACD2 mRNA | CTD | PMID:25583101 | oxaliplatin | multiple interactions | EXP | | 6480464 | [oxaliplatin co-treated with Topotecan] results in decreased expression of HACD2 mRNA | CTD | PMID:25729387 | paracetamol | increases expression | EXP | | 6480464 | Acetaminophen results in increased expression of HACD2 mRNA | CTD | PMID:33387578 | perfluorooctane-1-sulfonic acid | multiple interactions | ISO | Hacd2 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of HACD2 mRNA | CTD | PMID:36331819 | perfluorooctanoic acid | decreases expression | ISO | HACD2 (Homo sapiens) | 6480464 | perfluorooctanoic acid results in decreased expression of HACD2 protein | CTD | PMID:26879310 | phenobarbital | multiple interactions | ISO | Hacd2 (Mus musculus) | 6480464 | NR1I3 protein affects the reaction [Phenobarbital results in increased expression of HACD2 mRNA] | CTD | PMID:19482888 | phenobarbital | increases expression | ISO | Hacd2 (Mus musculus) | 6480464 | Phenobarbital results in increased expression of HACD2 mRNA | CTD | PMID:19482888 | pirinixic acid | multiple interactions | ISO | Hacd2 (Mus musculus) | 6480464 | [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of HACD2 mRNA | CTD | PMID:19710929 | pirinixic acid | increases expression | ISO | Hacd2 (Mus musculus) | 6480464 | pirinixic acid results in increased expression of HACD2 mRNA | CTD | PMID:18301758 more ... | propiconazole | increases expression | ISO | Hacd2 (Mus musculus) | 6480464 | propiconazole results in increased expression of HACD2 mRNA | CTD | PMID:21278054 | quercetin | decreases expression | ISO | HACD2 (Homo sapiens) | 6480464 | Quercetin results in decreased expression of HACD2 mRNA | CTD | PMID:21632981 | resveratrol | increases expression | ISO | Hacd2 (Mus musculus) | 6480464 | resveratrol results in increased expression of HACD2 protein | CTD | PMID:25505154 | testosterone | decreases expression | ISO | HACD2 (Homo sapiens) | 6480464 | Testosterone results in decreased expression of HACD2 mRNA | CTD | PMID:33359661 | tetrachloromethane | decreases expression | EXP | | 6480464 | Carbon Tetrachloride results in decreased expression of HACD2 mRNA | CTD | PMID:31150632 | thimerosal | decreases expression | ISO | HACD2 (Homo sapiens) | 6480464 | Thimerosal results in decreased expression of HACD2 mRNA | CTD | PMID:27188386 | topotecan | multiple interactions | EXP | | 6480464 | [oxaliplatin co-treated with Topotecan] results in decreased expression of HACD2 mRNA | CTD | PMID:25729387 | torcetrapib | increases expression | ISO | HACD2 (Homo sapiens) | 6480464 | torcetrapib results in increased expression of HACD2 mRNA | CTD | PMID:23228038 | triclosan | decreases expression | ISO | HACD2 (Homo sapiens) | 6480464 | Triclosan results in decreased expression of HACD2 mRNA | CTD | PMID:30510588 | valproic acid | increases expression | ISO | HACD2 (Homo sapiens) | 6480464 | Valproic Acid results in increased expression of HACD2 mRNA | CTD | PMID:23179753 | vorinostat | decreases expression | ISO | HACD2 (Homo sapiens) | 6480464 | vorinostat results in decreased expression of HACD2 mRNA | CTD | PMID:27188386 | |